These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33468501)

  • 41. [A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
    Suzuki K; Sekine T
    Kansenshogaku Zasshi; 2009 Nov; 83(6):669-72. PubMed ID: 20034323
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
    Suzuki K; Sekine T
    Kansenshogaku Zasshi; 2014 May; 88(3 Suppl 9-10):33-6. PubMed ID: 24979952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ulceration of the plantar vault. Ecthyma gangrenosum].
    Doss N; Dhaoui MR; Ben Sassi M
    Ann Dermatol Venereol; 2000 Oct; 127(10):849-50. PubMed ID: 11060395
    [No Abstract]   [Full Text] [Related]  

  • 44. Multiple ecthyma gangrenosum in a healthy infant with community-acquired Pseudomonas aeruginosa sepsis.
    Wu CT; Huang JL
    Pediatr Emerg Care; 2010 Oct; 26(10):750-1. PubMed ID: 20930597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral aspergillosis in a patient on ibrutinib therapy.
    Creuzet E; Nourrisson C; Chaleteix C; Poirier P; Moniot M
    Br J Haematol; 2021 Jun; 193(6):1025. PubMed ID: 33748950
    [No Abstract]   [Full Text] [Related]  

  • 46. Acute leukemia presenting as primary ecthyma gangrenosum.
    Koley S; Das G; Mandal RK; Barman DC; Mallick S; Kumar P
    Indian J Cancer; 2014; 51(4):598-9. PubMed ID: 26842208
    [No Abstract]   [Full Text] [Related]  

  • 47. Fever and skin lesions in a healthy 6-month-old boy. Diagnosis: Ecthyma gangrenosum.
    Mota-Burgos A; Villa AV; Noguera-Julian A; Fortuny C; González-Enseñat MA
    Pediatr Infect Dis J; 2012 Jul; 31(7):789, 794. PubMed ID: 22426298
    [No Abstract]   [Full Text] [Related]  

  • 48. Ublituximab plus ibrutinib versus ibrutinib alone for patients with relapsed or refractory high-risk chronic lymphocytic leukaemia (GENUINE): a phase 3, multicentre, open-label, randomised trial.
    Sharman JP; Brander DM; Mato AR; Ghosh N; Schuster SJ; Kambhampati S; Burke JM; Lansigan F; Schreeder MT; Lunin SD; Zweibach A; Shtivelband M; Travis PM; Chandler JC; Kolibaba KS; Sportelli P; Miskin HP; Weiss MS; Flinn IW
    Lancet Haematol; 2021 Apr; 8(4):e254-e266. PubMed ID: 33631112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orbital cellulitis, panophthalmitis, and ecthyma gangrenosum in an immunocompromised host with pseudomonas septicemia.
    Maccheron LJ; Groeneveld ER; Ohlrich SJ; Hilford DJ; Beckingsale PS
    Am J Ophthalmol; 2004 Jan; 137(1):176-8. PubMed ID: 14700664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ecthyma gangrenosum and severe neutropenic sepsis caused by
    Zhang X; Yu Y
    J Int Med Res; 2022 Sep; 50(9):3000605221126882. PubMed ID: 36168733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ecthyma gangrenosum: The critical role of biofilms and other mechanisms of antibiotic resistance and implications for management.
    Russomanno K; Cardis M; Kirkorian AY
    Pediatr Dermatol; 2021 Mar; 38(2):458-460. PubMed ID: 33389781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-Aspergillus invasive mould infections in patients treated with ibrutinib.
    Anastasopoulou A; DiPippo AJ; Kontoyiannis DP
    Mycoses; 2020 Aug; 63(8):787-793. PubMed ID: 32458510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ecthyma gangrenosum of the scrotum: a case report.
    Tan WP; Sherer BA; Hoeksema J
    Front Med; 2016 Mar; 10(1):101-3. PubMed ID: 26941196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ecthyma Gangrenosum of Scrotum in a Patient with Neutropenic Fever: A Case Report.
    Rodriguez JA; Eckardt PA; Lemos-Ramirez JC; Niu J
    Am J Case Rep; 2019 Sep; 20():1369-1372. PubMed ID: 31523051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ecthyma gangrenosum in a 3-year-old boy post-heart transplantation.
    Fukui KO; Shoji K; Nagai Y; Shindo T; Hikosaka M; Kuwahara K; Ishiguro A; Miyairi I
    Transpl Infect Dis; 2019 Aug; 21(4):e13131. PubMed ID: 31216602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ecthyma gangrenosum in patients with acquired immunodeficiency syndrome.
    Khan MO; Montecalvo MA; Davis I; Wormser GP
    Cutis; 2000 Aug; 66(2):121-3. PubMed ID: 10955192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ecthyma gangrenosum as a clue to pseudomonas septicaemia.
    Ribeiro M; Marinho P; Camilo C; Pinto S
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35318208
    [No Abstract]   [Full Text] [Related]  

  • 58. Early morphea during treatment with ibrutinib in a patient with chronic lymphocytic leukemia.
    Ozbagcivan O; Akarsu S; Nazli EC; Lebe B; Fetil E
    Ann Hematol; 2021 Jan; 100(1):293-294. PubMed ID: 32221651
    [No Abstract]   [Full Text] [Related]  

  • 59. Perineal ecthyma gangrenosum in infancy and early childhood: septicemic and nonsepticemic forms.
    Boisseau AM; Sarlangue J; Perel Y; Hehunstre JP; Taïeb A; Maleville J
    J Am Acad Dermatol; 1992 Sep; 27(3):415-8. PubMed ID: 1401278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
    del Giudice P; Cua E; Bernard E; Chichmanian RM; Oregionni O; Brucker F; Dellamonica P
    Arch Dermatol; 2006 Dec; 142(12):1663-4. PubMed ID: 17179011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.